Literature DB >> 10362050

The cellular composition of induced sputum in chronic obstructive pulmonary disease.

R A Peleman1, P H Rytilä, J C Kips, G F Joos, R A Pauwels.   

Abstract

Asthma and chronic obstructive pulmonary disease are characterized by airway inflammation, which can be assessed by bronchoscopic techniques as well as by the analysis of induced sputum. A method to induce sputum with inhaled hypertonic saline was adapted for use in 21 chronic obstructive pulmonary disease (COPD) patients (mean baseline forced expiratory volume in one second (FEV1) 1.60 L, or 54% predicted) and in 16 healthy volunteers. The success rate and safety of the method, were investigated along with the reproducibility of cell counts and differences in cell counts between both groups. All subjects produced adequate samples and the procedure did not alter spirometric values. A marked sputum neutrophilia was noted in patients with COPD (74.9+/-4.7%), whereas mainly macrophages were seen in healthy volunteers (74.0+/-4.0%). Reliability of the cell counts was high, both within investigators (r=0.99 neutrophils, r=0.99 macrophages) and between investigators (r=0.95 neutrophils, r=0.77 macrophages). In patients with COPD, an inverse correlation was noted between percentage of neutrophils and FEV1 (r(s)=-0.48, p<0.05). Immunostaining revealed a large proportion of activated macrophages in both groups. It was concluded that induction of sputum is a safe and reproducible method to study the composition of airway secretions in patients with chronic obstructive pulmonary disease.

Entities:  

Mesh:

Year:  1999        PMID: 10362050     DOI: 10.1034/j.1399-3003.1999.13d24.x

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  31 in total

1.  Inhibition of reactive nitrogen species production in COPD airways: comparison of inhaled corticosteroid and oral theophylline.

Authors:  T Hirano; T Yamagata; M Gohda; Y Yamagata; T Ichikawa; S Yanagisawa; K Ueshima; K Akamatsu; M Nakanishi; K Matsunaga; Y Minakata; M Ichinose
Journal:  Thorax       Date:  2006-09       Impact factor: 9.139

2.  [Effect of Yufeining on induced sputum interleukin-8 in patients with chronic obstructive pulmonary disease at the stable phase].

Authors:  Min-li Hong; Guo-zong Yang; Wen-xi Chen; Ling-yun Gao; Shao-hang Cai; Shun-zhen Dai
Journal:  Chin J Integr Med       Date:  2005-09       Impact factor: 1.978

Review 3.  Inflammatory cells in the airways in COPD.

Authors:  R O'Donnell; D Breen; S Wilson; R Djukanovic
Journal:  Thorax       Date:  2006-05       Impact factor: 9.139

4.  Induced sputum as a method for detection of systemic sclerosis-related interstitial lung disease.

Authors:  Neslihan Yilmaz; Yasin Abul; Muge Bicakcigil; Pejman Golabi; Cigdem Celikel; Sait Karakurt; Sule Yavuz
Journal:  Rheumatol Int       Date:  2011-03-30       Impact factor: 2.631

5.  Oxidative stress and airway inflammation in severe exacerbations of COPD.

Authors:  E M Drost; K M Skwarski; J Sauleda; N Soler; J Roca; A Agusti; W MacNee
Journal:  Thorax       Date:  2005-04       Impact factor: 9.139

6.  Exhaled leukotrienes and prostaglandins in COPD.

Authors:  P Montuschi; S A Kharitonov; G Ciabattoni; P J Barnes
Journal:  Thorax       Date:  2003-07       Impact factor: 9.139

Review 7.  New concepts in the pathobiology of chronic obstructive pulmonary disease.

Authors:  Victor Kim; Thomas J Rogers; Gerard J Criner
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

8.  Airways disease: phenotyping heterogeneity using measures of airway inflammation.

Authors:  Salman Siddiqui; Christopher E Brightling
Journal:  Allergy Asthma Clin Immunol       Date:  2007-06-15       Impact factor: 3.406

Review 9.  Inhaled corticosteroids in the long-term management of patients with chronic obstructive pulmonary disease.

Authors:  Don D Sin; S F Paul Man
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

10.  Relationship between peripheral airway dysfunction, airway obstruction, and neutrophilic inflammation in COPD.

Authors:  R A O'Donnell; C Peebles; J A Ward; A Daraker; G Angco; P Broberg; S Pierrou; J Lund; S T Holgate; D E Davies; D J Delany; S J Wilson; R Djukanovic
Journal:  Thorax       Date:  2004-10       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.